Significant correlations were found between serum PRM1 and CRC differentiation level in test cohort (P = 0.017) (Fig. 2l), and p53 status in validation cohort (P = 0.002) (Fig. 2m). This evidence concerns the gene TP53 and colorectal carcinoma.